PHS
CTSH icon

PFM Health Sciences’s Cognizant CTSH Stock Holding History

PFM Health Sciences’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-815,408
Closed -$49.8M – 82
2015
Q2 		$49.8M Buy
815,408
+815,358
+1,630,716% +$51.2M 1.26% 32
2015
Q1 		$3K Buy
+50
New +$2.95K ﹤0.01% 83

Other funds holding CTSH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PFM Health Sciences's CTSH Position: Q3 2015 in Review

PFM Health Sciences sold out of Cognizant (CTSH) in Q3 2015, closing a stake of 815,408 shares — an estimated $49.8M sold.

PFM Health Sciences first reported a position in CTSH in Q1 2015 and held it in 2 quarters. The position peaked at $49.8M in Q2 2015. 837 funds tracked by Wall St. Rank hold CTSH as of Q3 2015.

  • PFM Health Sciences reported no remaining Cognizant position as of Q3 2015 after selling out during the quarter.
  • PFM Health Sciences sold 815,408 Cognizant shares in Q3 2015, an estimated $49.8M.
  • PFM Health Sciences first reported a position in Cognizant in Q1 2015 and held it in 2 quarters.
  • PFM Health Sciences's Cognizant position peaked at $49.8M in Q2 2015.
  • 837 funds tracked by Wall St. Rank held Cognizant as of Q3 2015.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.